David Pacitti is Director of Health Sciences Acquisitions Corp 2. Currently has a direct ownership of 44,968 shares of HSAQ, which is worth approximately $0. The most recent transaction as insider was on Aug 07, 2025, when has been sold 15,000 shares (Common Stock, par value $0.0001 per share ("Common Stock")) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45K
156.29% 3M change
156.29% 12M change
Total Value Held $0

David Pacitti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2025
BUY
Grant, award, or other acquisition
-
15,000 Added 25.01%
44,968 Common Stock, par valu...
Jun 24 2025
BUY
Grant, award, or other acquisition
-
12,422 Added 29.3%
29,968 Common Stock, par valu...
Jun 20 2024
BUY
Grant, award, or other acquisition
-
5,376 Added 23.45%
17,546 Common Stock, par valu...
Mar 26 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 45.11%
12,170 Common Stock, par valu...

Also insider at

APEN
Apollo Endosurgery, Inc. Healthcare
DP

David Pacitti

Director
Austin, TX

Track Institutional and Insider Activities on HSAQ

Follow Health Sciences Acquisitions Corp 2 and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HSAQ shares.

Notify only if

Insider Trading

Get notified when an Health Sciences Acquisitions Corp 2 insider buys or sells HSAQ shares.

Notify only if

News

Receive news related to Health Sciences Acquisitions Corp 2

Track Activities on HSAQ